CytomX Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

CytomX Therapeutics

11/03/2024 21:01

* CytomX Therapeutics Inc  CTMX.OQ  reported quarterly
adjusted
earnings of 1 cent​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -43 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 3 cents per
share. Wall Street expected results to range from -24 cents
to 12 cents per share.
    * Revenue rose 2,712.6% to $26.61 million from a year ago;
analysts expected $21.04 million. 
    * CytomX Therapeutics Inc's reported EPS for the quarter was
1
cent​.
    * The company reported quarterly net income of $837
thousand.
    * CytomX Therapeutics Inc shares had risen by 61.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 19.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for CytomX
Therapeutics Inc is $3.00 
This summary was machine generated from LSEG data March 11 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.03          0.01           Beat
 Sep. 30 2023      -0.19          0.04           Beat
 Jun. 30 2023      -0.20          -0.02          Beat
 Mar. 31 2023      -0.11          -0.05          Beat